Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Endocrinology and Diabetes


This project aims to develop incretin therapy as a glucose-reducing strategy in type 2 diabetes (T2D). Its particular focus is to understand the mechanisms of incretin therapy and to optimize its clinical positioning. This mission is achieved by an interdisciplinary approach with complementary studies in subjects with T2D, healthy volunteers and experimental animals.

Recent research outputs

Bo Ahrén, 2019 Jun 19, In : Frontiers in Endocrinology. 10, JUN, 376.

Research output: Contribution to journalArticle

Ahmadi, S., Karin Filipsson, Dimenäs, H., Isaksson, S., Imberg, H., Sjöberg, S., Bo Ahrén, Dahlqvist, S., Gustafsson, T., Tuomilehto, J., Hirsch, I. & Lind, M., 2019, In : Obesity Science Practice. 5, 2, p. 130-140

Research output: Contribution to journalArticle

View All (39)